Julia Newman

PrEP-ception: Using PrEP to Reduce HIV Transmission Risk During Conception

By Julia Newman | May 1, 2014 | Comments Off on PrEP-ception: Using PrEP to Reduce HIV Transmission Risk During Conception

We don’t have a cure for AIDS yet, but, in 2012, the Food and Drug Administration (FDA) approved daily use of Truvada (an anti-retroviral drug combination containing tenofovir and emtricitabine) for “Pre-Exposure Prophylaxis (PrEP)” to reduce the risk of HIV transmission during sexual intercourse.